Pharmacy in the U.S. appears to be at a breaking point–driven to this stage in large part by the still-evolving demands from COVID-19 and also by a shortage of human resources. A similar story is unfolding in Canada.
The European Union's drug regulator said it has started evaluating the coronavirus pill made by Pfizer Inc. to see if it might be used in emergency situations before it is officially authorized.